- Home
- KURA vs ADSE Comparison
KURA vs ADSE Comparison
Compare KURA & ADSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KURA | ADSE |
|---|---|---|
| Founded | 2014 | 1980 |
| Country | United States | Ireland |
| Employees | N/A | 302 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 841.6M | 847.5M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | KURA | ADSE |
|---|---|---|
| Price | $11.04 | $12.19 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $25.56 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 10.2K |
| Earning Date | 05-12-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,482,000.00 | N/A |
| Revenue This Year | $28.28 | $549.86 |
| Revenue Next Year | $106.37 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.24 | N/A |
| 52 Week Low | $5.45 | $7.89 |
| 52 Week High | $12.49 | $13.50 |
Technical Indicators
Market Signals| Indicator | KURA | ADSE |
|---|---|---|
| Relative Strength Index (RSI) | 64.71 | 57.44 |
| Support Level | $8.53 | $11.20 |
| Resistance Level | $11.29 | $12.28 |
| Average True Range (ATR) | 0.49 | 0.71 |
| MACD | 0.12 | 0.12 |
| Stochastic Oscillator | 89.29 | 78.70 |
Price Performance
Historical ComparisonAbout KURA Kura Oncology Inc.
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
About ADSE ADS-TEC ENERGY PLC
ADS-TEC Energy PLC produces, develops, and markets battery-buffered EV charging systems infrastructure, battery storage systems, and cloud-based services that enable the customer to control and manage the system. The company generates revenue mainly through the sale of its products, services, and Big-LinX. Geographically, it derives a majority of its revenue from Germany.